CDKN2A and hepatocellular carcinoma: The expression of CDKN2A (Figures 8A, p = 2.9e-05), DLTA (Figure 8B, p = 0.027), GLS (Figure 8D, p = 0.0056) was significantly different at the pTNM stage in HCC.